Abstract
Nociceptin/orphanin FQ (N/OFQ) produces several biological actions by activating the N/OFQ peptide receptor (NOP). It has been previously shown that N/OFQ stimulates leukocyte chemotaxis both in vitro and in vivo. In the present study we investigated the ability of N/OFQ, in comparison with the proinflammatory peptide formyl-Met-Leu-Phe (fMLP), to stimulate human neutrophil and monocyte chemotaxis and the release of lysozyme and superoxide anion (O 2 −) production from neutrophils. fMLP stimulated all the leukocyte functions examined. N/OFQ stimulated monocyte (pEC 50 12.15) but not neutrophil chemotaxis. The production of O 2 − from neutrophils was not affected by N/OFQ while the release of lysozyme was increased in a concentration dependent manner (pEC 50 11.00) although the maximal effects evoked by N/OFQ were about half of those of fMLP. The NOP ligands [Arg 14, Lys 15]N/OFQ, N/OFQ(1-13)NH 2, Ro 64-6198, UFP-101 and the opioid antagonist naloxone were used for pharmacologically characterizing the receptor involved in the monocyte chemoattractant action of N/OFQ. [Arg 14, Lys 15]N/OFQ, N/OFQ(1-13)NH 2, and Ro 64-6198 mimicked the action of N/OFQ showing similar maximal effects and the following order of potency: [Arg 14, Lys 15]N/OFQ (pEC 50 13.22) > Ro 64-6198 (pEC 50 12.96) > N/OFQ(1-13)NH 2 (pEC 50 12.67) > N/OFQ (pEC 50 12.15). Moreover, the monocyte chemoattractant action of N/OFQ was not modified by naloxone 1 μM while antagonized by UFP-101 10 μM (pA 2 7.00). Thus, the order of potency of agonists and the antagonist selectivity demonstrated that N/OFQ stimulates human monocyte chemotaxis via NOP receptor activation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have